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AbstracL  We have previously shown that postnatal 
expression of the viral oncoprotein SV40 T antigen in 
rod photoreceptors (transgene MOT1), at a time when 
retinal cells have withdrawn from the mitotic cycle, 
leads to photoreceptor cell death (A1-Ubaidi  et al., 
1992.  Proc.  Natl.  Acad.  Sci.  USA.  89:1194-1198).  To 
study the effect of the specificity of the promoter, we 
replaced the mouse opsin promoter in MOTI by a  1.3- 
kb promoter fragment of the human IRBP gene which 
is expressed in both rod and cone photoreceptors dur- 
ing embryonic development. The resulting construct, 
termed HIT1,  was injected into mouse embryos and 
five transgenic mice lines were established. Mice het- 
erozygous for HIT1 exhibited early bilateral retinal 
and brain tumors with varying degrees of incidence. 
Histopathological examination of the brain and eyes of 
three of the families showed typical primitive neuro- 
ectodermal tumors. In some of the bilateral retinal 
tumors, peculiar rosettes were observed, which were 
different from the  Flexner-W'mtersteiner rosettes  typi- 
cally associated with human retinoblastomas. The 
ocular and cerebral tumors, however, contained 
Homer-Wright rosettes, and showed varying degrees of 
immunoreactivity to antibodies against the neuronal 
specific antigens, synaptophysin and Leu7, but not to 
antibodies against photoreceptor specific proteins. 
Taken together, the results indicate that the specificity 
of the promoter used for T antigen and/or the time of 
onset of transgene expression determines the fate of 
photoreceptor cells expressing T antigen. 
XPRESSION of viral  oncogenes  typically  promotes 
tumorigenesis in various tissues of transgenic mice 
(18, 29).  The oncogene that  was  most frequently 
used to induce tumor formation is simian virus 40 (SV40) 
large tumor antigen (T antigen) (18, 29), which is essential 
for both viral replication and cell transformation  (8, 37). T 
antigen has been found to interact with several cellular pro- 
teins involved in tumor suppression (12, 23), DNA replica- 
tion (14), and regulation of transcription (15, 38), but its pre- 
cise role in oncogenesis is not well understood. Accidental 
expression of SV40 T antigen in the retina of  transgenic mice 
has led to the generation of tumors originating  in various 
retinal  cell types (4,  17,  21,  36),  except photoreceptors. 
Brain and retinoblastomalike  ocular tumors originating  in 
the inner nuclear layer were induced in one of fifteen trans- 
genic families that harbored a hybrid gene consisting of the 
human/~-luteinizing hormone gene promoter and the T anti- 
gen gene (39). Inheritable human retinoblastomas,  typically 
caused by a defect in the rb gene, arise from retinal  em- 
bryonic neuroepithelial  cells and often express components 
of  the cone, but not the rod phototransduction cascade in tis- 
sue culture (5, 20). 
We previously showed that T antigen expression driven by 
the  mouse opsin  promoter caused an  early and  rapidly 
progressing  rod photoreceptor degeneration, and at a later 
stage,  the development of brain tumors (2).  The rod pho- 
toreceptor degeneration, as evidenced by pyknotic nuclei 
and shrinkage of the outer nuclear layer, began around post- 
natal day 8 (P8), and was complete by P21. T antigen expres- 
sion, under control of the opsin promoter, was shown to be- 
gin between P1 and P5, and reached maximum levels before 
onset of the degeneration. In the retina, rod opsin is ex- 
pressed exclusively  in  rods,  whereas interphotoreceptor 
retinoid-binding protein (IRBP) 1 is known to be expressed 
in both rods and cones (31). Both proteins are expressed to 
a much lesser extent in pinealocytes in the brain (24). Ex- 
pression of IRBP precedes expression of rhodopsin,  and can 
be detected at embryonic day 17 (El7) (9). Expression of a 
bacterial reporter gene (chloramphenicol  acetyltransferase, 
CAT) under the control of the human IRBP promoter indi- 
cated an even earlier onset of expression (27). To study the 
effect of onset of expression of T antigen and the cell type 
specificity of the promoter, the human IRBP promoter frag- 
ment was used to direct expression of T antigen to the retina 
1. Abbre~ations used in this paper: CAT, chloramphenicoI acetyltransfer- 
ase;  GFAP, gliat  flbrillary  acidic  protein;  IRBP, interphotoreeeptor 
retinoid-binding protein;  NF, neurofilament; nt, nucleotides;  PDE, phos- 
phodiesterase. 
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SV40 T antigen under the control of a  1.3-kb human IRBP 
promoter fragment causes the formation of trilateral tumors 
involving the eyes and brain. Bilateral retinal tumors appear 
to arise in the outer nuclear layer of the retina. 
Methods 
Production of rdlrd, Cat/+  Mice 
Mice homozygous for the rd mutation exhibit complete degeneration of the 
photoreceptor cell layer about the third week of postnatal development (28). 
FVB/N (rd/rd)  mice and transgenic mice homozygous for the IRBP/CAT 
transgene were mated,  and FI mice, heterozygous for both rd and IRBPI 
CAT, were then mated to FVB/N to produce mice that are homozygous for 
the rd mutation and hetercczygous for the IRBPICAT transgene. Mice that 
were heterozygous for both the IRBP/CAT and rd were used as controls. 
The presence of the rd allele was detected by the rd specific DdeI poly- 
morphism (30). The IRBP/CAT transgene was detected as described pre- 
viously (24). 
RNAse Protection Assay 
Fragments of antisense RNA (259 or 392 nucleotides [nt] for mouse IRBP, 
363 nt for CAT, and 300 nt for ~ actin) were synthesized in the presence 
of [~t-32p]uTP using "1"3 or T7 RNA polymerase  (Promega Corp., Madi- 
son,, WI) using corresponding linearized subclones in Bluescript plasmid 
(25).  The synthesized probes  were gel purified and were used in excess 
(200-900 pg) to hybridize with 0.1 #g ofpoly(A) mRNA or 2 Itg total RNA. 
Hybridization  was carried out at 42"C overnight in the presence of 50% 
deionized formamide, 40 mM Pipes pH 6.4, 400 mM NaOAc and I mM 
EDTA. After hybridization the mixture was treated with I0  units  of RNAse 
A and 2,000 U of RNAse T1, and protected fragments were separated by 
polyacrylamide  gel  electrophoresis.  Autoradiographs  were  quantitated 
using a Shimadzu densitometer. The sizes of protected fragments were: 245 
or 311 nt for mouse IRBP;  108 nt for mouse opsin; 309 nt for CAT; and 
250 nt for O-actin. 
Chloramphenicol Acetyltransferase Assay 
CAT activity was measured in retinas or eyes (at early embryonic stages) 
as described previously (19). One unit of CAT activity was defined as the 
amount of activity capable of acetylating  1 mmol of chloramphenicol/min 
at 37~  Protein concentrations  were determined by the Bradford method 
(Bio-Rad Laboratories,  Richmond,  CA) (6). 
Preparation of the HIT1 Construct 
The 5' flanking fragment of the human IRBP gene was digested with PvuII 
and ligated to Sinai digested pUC18 to produce phIRBP-1.3, phIRBP-1.3 was 
then digested with EcoRI and BamHI and the gel purified fragraent of the 
human  IRBP promoter  was inserted  into the EcoRI/BamHI  sites of the 
promoterless plasmid paA366a-T (26). The resultant construct (HIT1) was 
digested with BstUI to yield a 4.5-kb fragment containing the human IRBP 
promoter sequences, the entire coding sequences for the SV40 T antigen, 
and some flanking sequences from the plasmid pBR322. 
Generation of HIT1 Transgenic Mice 
Transgenic  mice were produced  using  previously  established  protocols 
(29), where the BstUI fragment of the HIT1 construct  (at 1 mg/ml in 10 
mM Tris, 0.1 mM EDTA, pH 8.0) was injected in single cell mouse em- 
bryos. Ttansgenic founder mice (F0) were identified by either blot hybrid- 
ization or by PCR (2). For PCR analysis, DNA extracted from ear punches 
was used  in an amplification  reaction  in the presence  of human  IRBP 
specific primer (5' CAGTGTC~TGTAGCAGG 3') and a T antigen 
specific primer (5' CATCCTCAGTAAGCACAGCA  3') which produced 600 
bp fragment upon amplification.  Founder mice were mated to C57BL/6 
mice to produce the first (FI)and subsequent generations of mice used for 
the study. Blot analysis was performed as described (33) and washings were 
performed  at 55~ 
Histology 
Transgenic mice with  brain  and rctinai  tumors were killed  by  cervical dislo- 
cation  and the eyes and brains removed and fixed in 4 % phosphate-buffered 
formaldehyde. Tissues were embedded in paraffin and 5 #m sections of the 
eye and brain were cut, stained with hematoxylin-cosin,  and examined. 
Immunocytochemistry 
The ocular and brain tumors were fixed  in 10% buffered  formalin solution. 
Four micron sections  of the tumors were prepared  and the sections  were 
deparalfmized and hydrated in decreasing ethanol concentrations.  Incuba- 
tion of the sections with the primary  antibody followed by the secondary 
antibody and finally the avidin-biotin complex method (kit and methods ob- 
tained from Fisher Scientific Co., Pittsburgh, PA) were all performed in a 
moist chamber at 37"C. As chromogen, amino-ethyl carbazole was used. 
Sections  were countctstained  with  Mayer's hematoxylin for 1 rain. Immuno- 
cytechemical staining tO deraonstrate photoreceptor  specific antigens were 
performed using the following antibodies: bovine opsin (gift from Dr. Paul 
Hargmve [University of Florida, Oainesville, FL], R2-12N and K16-155C 
[1]), bovine phosphodiesterase (gift from Dr. Bernard Fang [UCLA School 
of Medicine, Los Angeles, CA], MOEI), and S antigen (gift from Dr. Larry 
Donoso [Wills Eye Hospital, Philadelphia, PA], MAB-AgC6 [13]). Hybri- 
domas  producing  antibodies  against T  antigen (PAB100) were obtained 
from the American ~  Culture  Collection (Reckville,  MD) (16). Anti- 
bodies against synaptophysin (Boehrin~r  Mannheim Corp., Indianapolis, 
IN), cytokeratins  (Boehringer  Mannheim),  and antibodies  against  Lea7 
(Becton Dickinson Immunocytometry Systems, Mountain View, CA) were 
also used. Antibodies against glial fibrillary acidic protein (GFAP), neuron- 
specific enolase (NSE) and neurofilament (NF) were obtained from Dako 
Corp. (Santa Barbara, CA). For controls, eyes and brains from normal lit- 
termates were used. 
Results 
Onset of Gene Expression Under the Control of the 
hlRBP Promoter 
The  hIRBP  promoter  directs  expression  of  a  bacterial 
reporter gene, CAT, to the retina and to a much lesser extent 
to the brain (pinealocytes)  of transgenic animals (24).  To 
study  t~e onset of CAT expression in the embryonic retina 
of a  transgenic  mouse  heterozygous  for  the  hIRBP/CAT 
transgene,  we determined the amount of CAT transcripts  at 
various stages of embryonic development by an RNase pro- 
tection assay (RPA). Fig.  1 shows that CAT transcripts  and 
hence transgene expression under the control of the IRBP 
promoter can be detected as early as E13, at least one week 
earlier than opsin expression (3). 
Cell Specificity 
To study the cell specificity of the IRBP promoter, we used 
a  genetic  approach  in  which  mice  homozygous  for  the 
IRBP/CAT transgene were mated with mice homozygous for 
the rd locus. Mice heterozygous for the rd allele develop nor- 
real retinas  (32),  while mice homozygous for the rd allele 
suffer a rod photoreceptor degeneration. CAT activity in the 
retinas of offspring homozygous for the rd allele and hetero- 
zygous  for IRBP/CAT  were assayed  at diiferent stages  of 
postnatal  development.  Mice  that  were  heterozygous  for 
both the rd allele and IRBP/CAT transgene served as con- 
trols. As seen in Fig. 1, CAT activity in both rd/rd and rd/+ 
animals rose during the first few days of retinal development. 
A sharp increase was seen at P7, a time when the last mitotic 
figures are normally observed in the retina of the mouse (10, 
41).  While CAT activity in the rd/+  animals continued to 
rise, after an initial decline, a pronounced decrease of CAT 
activity in the retina of rd/rd animals was observed. This de- 
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Figure L  CAT expression during prenatal and postnatal develop- 
ment of  the retina. Prenatal expression of  the hlRBP/CAT  transgene 
was monitored by RNase protection. Postnatal expression of the 
transgene was measured by assaying CAT activity (mU/mg protein) 
(24). Retinal samples were obtained from mice at different stages 
of postnatal development. Diamonds represent the amount of CAT 
transcripts, as determined quantitatively from an autoradiogram. 
Triangles represent activity in retinas from mice that are heterozy- 
gous for both the rd allele and the CAT transgene, whereas circles 
represent activity in retinas of animals homozygous for the rd allele 
and heterozygous for the CAT transgene. Error bars are calculated 
from three different experiments of  the same tissue and at least three 
different samples. 
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Figure 2. Transgenic constructs. Upper part: organization of  the hu- 
man IRBP gene. The filled boxes depict coding sequences, lines de- 
pict introns and flanking regions. Open boxes represent the 5' and 
3' untranslated regions of the exons. The 1.3-kb promoter region 
of the human IRBP gene (heavy line) is flanked by two PvulI sites. 
Transgene hlRBP/CAT: The 1.3 kb hIRBP promoter fragment was 
fused to the CAT gene as described (24). The stippled box depicts 
the SV40 small t antigen intron and the SV40 early region polyade- 
nylation site. Transgene HITI: The 1.3-kb PvulI fragment contain- 
ing the human IRBP promoter sequences was fused to the 5' end 
of the SV40 T antigen gene with its own polyadenylation signals 
contained in the plasmid PaA366a-T (26). Dotted box, genomic se- 
quences upstream of the aA-crystallin  promoter. Tsp depicts the 
transcription start site of  the human IRBP gene. Hatched box, SV40 
T antigen coding sequence. The 4.3-kb BstUI restriction fragment 
used for microinjection is shown. 
cline in CAT activity continued until it reached a constant 
level of 8-10% of the activity in control retinas at postnatal 
day 21. The reduction of CAT activity is associated with rod 
photoreceptor degeneration, usually completed at about the 
end of the third week of  postnatal development (28). Because 
cone photoreceptor cells have been detected in rd/rd mice as 
late as 6 mo of age (22), persisting cone photoreceptor cells 
most likely continued to express CAT activity at P20 (Fig. 
1). Because all other cell types in the retina remain intact, 
these results indicate that the hIRBP promoter directs ex- 
pression  of the  bacterial  CAT  gene  specifically  to  pho- 
toreceptor cells. 
The HITI Construct 
To study the effect of onset of expression of SV40 T antigen 
in  the  developing  photoreceptor cell  layer  of transgenic 
mice, the hIRBP promoter was fused to the SV40 large T an- 
tigen sequences to yield construct HIT1 (Fig. 2). HIT1 con- 
tains the transcription start site and upstream promoter of  the 
human IRBP gene, and the complete coding sequences of the 
viral oncogene. In addition to an early onset of T antigen ex- 
pression, the IRBP promoter is expected to direct expression 
of  the antigen to both rods and cones. HIT1 was injected into 
1-d old  FVB/N  mouse  embryos (35)  and  five transgenic 
founder mice were established.  Southern blot analysis of 
genomic DNA from the founder mice and their offspring 
(data not shown) from a mating to C57BL/6 showed a Men- 
delian fashion of inheritance of the transgene and indicated 
the integration of multiple copies of the transgene at single 
sites (Table I). 
Expression of HITl Causes Trilateral Tumors 
All of the transgenic mice families that harbored HITI ex- 
hibited retinal and brain tumors, albeit at varying incidence 
levels (Table I). The tumors were consistently trilateral and 
appear to initiate at embryonic or early postnatal  stages. 
Most ocular and  brain  tumors were poorly differentiated 
with a variable degree of anaplasia and bizarre pleomorphic 
nuclei.  The ocular tumors led to total retinal detachment 
with the tumor cells involving mostly the outer retinal layers 
(Figs. 3 A and 4 A). The inner retina (inner plexiform and 
ganglion cell layers) appeared intact and in many sections, 
the tumor cells merged imperceptibly with the bipolar cell 
layer (Fig.  4  A).  While  most of the ocular tumors were 
poorly differentiated, some tumors were more differentiated 
and disclosed peculiar rosettes composed of a single layer of 
cuboidal cells that were centered around a small capillary 
lined by a single layer of fiat endothelial cells (Fig,  3 B), 
Table L Characterization of Transgenic Mice Families 
Harboring the HIT1 Fusion Gene 
Family (F0) 
Characteristics  408  413  414  417  437 
Phenotype  None  BT, ET  BT, ET  BT, ET  BT, ET 
Tumor incidence (%)  1  95  63  100  100 
Transmittance (%)  43  38  55  50  50 
Integration site(s)  1  1  1  1  1 
Copies per haploid  2  8  2  3  9 
Southern analysis (33) performed on tail DNA samples of the founder mice and 
their offspring from a mating to C57BL/6, was used to obtain the number of 
copies of the transgene, the number of sites of integration and rate of transmit- 
tance of the transgene. A total  of 145 mice from different families were in- 
volved in generating these results. Tumor incidence (%)  was calculated by 
dividing the number of mice that developed tumors after weaning by the total 
number of weaned mice for each transgenic family. BT, brain tumor; ET, eye 
tumor. 
AI-Ubaidi et al, Expressing hlRBP/T Antigen Causes Trilateral Tumors  1683 Figure 3. Histopathological characterization of the retinal and brain tumors. (A) Section of an enucleated right eye from a 60-d old mouse 
(F0 417) displaying a large retinal tumor 0aematoxylin-eosin, 27X). The tumor originates from the outer retinal layers and extends into 
the subretinal space. (B) Retinal tumor from a mouse killed at age 45 d. (F0 417) showing  a primitive neuroectodermal neoplasm containing 
neuroepithelial rosettes, most of which are centered around a capillary (arrow) (hematoxylin-eosin, 345X). (C) Brain tumor from a mouse 
(F0 413) killed at age 60 d (hematoxylin-eosin, 57X). The mass of poorly differentiated tumor cells is located adjacent to the habenular 
nuclei (asterisks). (Arrow) ependymal cells; (small black arrowhead) choroid plexus; (black squares) dentate gyri. The enlarged aqueduct 
(large black arrowhead) is due to the severe hydrocephalus caused by the growth of the tumor. (D) Midbrain tumor section from a mouse 
killed at age 45 d (family 417) showing the Homer-Wright rosette formation (arrow) (hematoxylin-eosin, 270X). 
Scattered erythrocytes were usually observed in the lumens 
of the capillaries (Fig. 3 B). Characteristic Flexner-Winter- 
steiner rosettes,  typically associated with retinoblastomas 
(34),  could not be identified, but the less specific Homer 
Wright rosettes (34) were clearly observed in both the retinal 
and brain tumors (Figs. 3 D, and 4 A). Coronal sections of 
the brain tumors revealed poorly differentiated neoplasms 
with the histologic features usually encountered in primitive 
neuroectodermal tumors of infancy (Fig. 3 C). The cerebral 
tumors involved mostly the diencephalon, adjacent to the 
third ventricle, and surrounded the aqueduct and the habenu- 
lar nuclei without involving the choroid plexus (Fig. 3 C). 
The tumors also extended to the midbrain and fourth ventri- 
cle. The cerebral neoplasms were quite advanced at the time 
the animals were killed.  Many tumor cells showed wide- 
spread leptomeningeal infiltration along the Virchow-Robin 
spaces surrounding the blood vessels as they enter the brain. 
By electron microscopy, the tumor cells showed large pleo- 
morphic nuclei with formation of nuclear blebs and numer- 
ous polyribosomes, scattered mitochondria and dilated cis- 
ternae of smooth-surfaced endoplasmic reticulum (Font et 
al., unpublished results). The exact origin of the tumor was 
not clearly discernible in the sections examined. 
Although the retinal and brain tumors were highly un- 
differentiated, the neoplastic cells reacted with antibodies to 
neuron-specific enolase, S antigen and Leu7. S-antigen (ar- 
restin) is not a photoreceptor specific protein and has been 
identified in the non-neoplastic state in pinealocytes, lens 
fiber,  and epithelial cells,  cerebellum and cerebral cortex 
(7), and also in several primitive neuroectodermal tumors of 
man (21). The tumor cells were not reactive with either anti- 
bodies against neurofilament and GFAP, or with photorecep- 
tor specific antibodies (see legend of  Table II), but were reac- 
tive with antibodies to T  antigen (Fig. 4 B). 
Discussion 
Expression of  SV40 T antigen in the retina of  transgenic mice 
driven  by the  mouse  opsin  promoter  leads  to  a  rapidly 
progressing retinal degeneration associated with sustained 
DNA synthesis and mitotic cycles in the cells of the outer nu- 
clear layer (2). To investigate whether the onset of  expression 
of the oncogene or the cell specificity of the promoter is 
responsible  for  the  resulting  phenotype,  another  retina 
specific promoter was used to direct expression of T antigen 
to the photoreceptor cells of transgenic mice. The human 
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and Brain Tumors 
Antibodies against 
Mouse (F0)  NSE  Synapto.  Leu 7  T antigen  S antigen 
666 OD  (417)  +  +  -  +f  NP  +f 
666 OS  (417)  +  +  +  +f  NP  - 
666 Br  (417)  +  +  +  +f  NP  +  + 
1257 OD  (417)  -  +  NP  NP  NP 
1257 Br  (417)  NP  ++  +  +  NP  ++ 
1258 OS  (417)  NP  +++f  +f  +f  -if 
1258 Br  (417)  NP  +  +f  +f  +f  +f 
726 OD  (437)  -  +f  +f  NP  - 
726 OS  (437)  -  +  +  -  +f  +f 
726 Br  (437)  +  +  -  +f  +  + 
916 Br  (437)  +  +  +  -  -  +  + 
Immunoreactivity of tumors to different antibodies were assessed by staining 
sections with the avidin-biotin immunoperoxidase  method and using hematoxy- 
lin as counter stain. The presence of brown precipitant was used to indicate im- 
munoreactivity. All mice were adult when killed,  but the developmental stage 
of the tumor differed  depending on the individual mouse. The results shown 
were from an average of 15 sections from each antibody. Column mouse Fo, 
founder mouse nomenclature (Br, brain; OS, left eye; OD, right eye. Numbers 
in parentheses refer to individual mouse families). NSE, neuron-specific eno- 
lase; Synapto.; synaptophysin; Leu 7, human natural killer cells specific anti- 
gen. f, focal (few foci only); NP, not performed;  +, weak;  ++,  moderate; 
+ + +,  strong;  -,  negative. Immunohistochemical stains for glial fibrillary 
acidic protein (GFAP), neurofilament (NF), rhodopsin, and rod cGMP phos- 
phodiesterase (PDE) were negative (not shown). 
IRBP-promoter has previously been used to direct expres- 
sion of the bacterial CAT gene to the retina and pineal gland 
of transgenic mice (24). Expression of the IRBP/CAT trans- 
gene,  irrespective of the site of integration, starts at em- 
bryonic day 13 (Fig. 1), a time when developing retinal cells 
have just begun the initial differentiation into rod and cone 
photoreceptor cells (40). Utilizing a hybrid gene composed 
of the human IRBP promoter  and  the bacterial B-galac- 
tosidase gene, Yokoyama et al. (40) detected expression in 
both rod and cone photoreceptor cells similar to the pattern 
of expression of the endogenous IRBP gene (31). We chose 
to test the tissue specificity of the human IRBP promoter by 
following the CAT activity in the retina of mice homozygous 
for the rd mutation. The rod photoreceptor cells of these 
mice rapidly degenerate starting at P10, while nuclei of the 
cone photoreceptor cells survive for at least 6 mo (28).  We 
allowed matings of  IRBP/CAT transgenic mice to rd/rd mice 
and selected for mice that are homozygous for the rd allele 
and carry the IRBP/CAT transgene. Our results show that ex- 
pression of the CAT gene was directed to the photoreceptor 
cell layer in the retinas of the transgenic animals. 
Because hlRBP/CAT transgene expression was shown to 
start as early as El3, this promoter was chosen to direct T 
antigen expression to the retina of  transgenic mice. We found 
that expression of T antigen driven by the hIRBP promoter 
led to the formation of  tumors in the brain and retina of  mice. 
Tumors occurred at varying degrees of severity in different 
transgenic families, and this was most likely due to the effect 
of site of integration on the levels of expression of the trans- 
gene. Animals exhibiting retinal tumors consistently devel- 
oped  brain  tumors,  unlike  the  mouse  model  for  retino- 
blastoma  reported  earlier  (39)  where  only  27%  of  the 
transgenic mice produced brain tumors whereas  100%  of 
transgenic animals produced retinal tumors. This variation 
in the levels of tumor occurrence has been attributed to the 
effect of the site of integration of the transgene on the levels, 
cell type, or onset of expression (39).  We also observed 
tumors in all founder mice that were homozygous for the rd 
mutation, suggesting that either tumors arose from surviving 
cone cells (22) or from photoreceptor cells before the onset 
of degeneration. We favor the latter possibility due to the 
early onset of expression of the transgene driven by the hu- 
man IRBP promoter. 
Normal retinal photoreceptor cells show varying degrees 
of reactivity  to  neuronal  specific  antibodies.  Antibodies 
directed against neuron specific enolase, S antigen and Leu7 
show moderate to intense labeling of photoreceptor cells 
(11). However, photoreceptor cells show little or no reactiv- 
ity with antibodies  against neurofilaments, synaptophysin 
and GFAP. Therefore, it is not surprising that neuron specific 
enolase, S antigen and Leu7 were detected in the tumors. It 
Figure 4. (A) Neuronal specific  enolase staining of  a retinal tumor (120X) for a 90-d old mouse (F0 437). Tumor, which is in close proximity 
to the lens (asterisk)  shows  the readily identifiable  intact inner retinal layers (arrowhead).  Also shown  is the Homer-Wright  rosette formation 
(arrow). (B) Immunodetection  of T antigen in the retinal tumor of a mouse (family 417) killed at age 60 d (305X). Tumor cells in active 
mitosis (arrows)  display positive staining for T antigen. 
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activity with antibodies against GFAP and neurofilament be- 
cause the tumors arose from the retinal outer layer. However, 
while normal  photoreceptor cells did not react with anti- 
synaptophysin antibodies,  the tumor calls reacted moder- 
ately.  This  result combined with the  negative  staining  of 
tumor cells with anti-opsin and anti-phosphodiesterase ant.i- 
bodies (not shown) suggest that either the tumors lost expres- 
sion of some antigens and gained expression of others, due 
to the transformation by T antigen, or the early onset of ex- 
pression of T antigen in the stem cells before the final differ- 
entiation  into rod and cone photoreceptors.  Immunoreac- 
tivity to T antigen was restricted to mitotically active cells 
(Fig. 4 B), which may be caused by the accumulation of T 
antigen before the mitotic division. 
The  tumors  observed in  transgenic  animals  expressing 
HIT1  were of highly  undifferentiated  nature and therefore 
were designated primitive neuroectodermal tumors. The de- 
velopment of retinal  tumors in animals  carrying  HIT1, in 
contrast  to  the  earlier  observed  retinal  degeneration  in 
animals carrying MOT1 (2) may have been due to expression 
of HIT1 in both the rod and cone photoreceptor cells. There- 
fore, while rod photoreceptor cells degenerated, differentiat- 
ing cone photoreceptor cells may have reacted differently to 
the expression of an oncogene resulting in the formation of 
tumors.  This may explain the previous detection of cone- 
specific and the absence of rod photoreceptor-specific anti- 
gens in retinoblastomas  (5,  20).  Alternatively,  the earlier 
onset of expression of T antigen driven by the human IRBP 
promoter may be responsible for the formation of tumors. 
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